DDR1 and non-small cell lung carcinoma: We treated the NSCLC cell lines A549, NCI-H1703, and NCI-H358 with NSC632839, and after 16 h, a dose-dependent decrease in DDR1 protein levels and cell viability was observed (Fig. 2, A and B).